Seratrodast, CAS [[112665-43-7]]

Produktübersicht

• Artikelname: Seratrodast, CAS [[112665-43-7]]
• Artikelnummer: MCE-HY-B0774
• Hersteller Artikelnummer: HY-B0774
• Alternativnummer: MCE-HY-B0774-5MG,MCE-HY-B0774-10MG,MCE-HY-B0774-100MG,MCE-HY-B0774-50MG,MCE-HY-B0774-25MG,MCE-HY-B0774-10MMX1ML
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: AA 2414

Produktbeschreibung

Seratrodast (AA 2414), an orally active antiasthmatic agent, is a thromboxane A2 receptor (TP) antagonist and ferroptosis inhibitor. Seratrodast reduces lipid ROS production, modulates the systemic xc-/GSH/GPX4 axis, and inhibits JNK phosphorylation and p53 expression. Seratrodast exhibits anti-asthmatic and anti-epileptic activity[1][2][3].

Produkteigenschaften

• Molekulargewicht: 354.44
• Reinheit: 99.59
• CAS Nummer: [112665-43-7]
• Formel: C22H26O4
• Target-Kategorie: Ferroptosis,JNK,MDM-2/p53,Prostaglandin Receptor,Reactive Oxygen Species (ROS)

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound1